The AACE consensus statement emphasizes improvement of overall health in addition to weight reduction among adults with obesity and adiposity-based chronic disease.
The first oral GLP-1 medication for weight loss has been approved for use in the U.S. The Wegovy pill, from drugmaker Novo Nordisk, was cleared by the Food and Drug Administration to reduce excess ...
CagriSema achieved 23% weight loss after 84 weeks of treatmentCagriSema 2.4/2.4 mg did not meet the primary endpoint of ...
Weight-loss programs abound on the internet, from customized plans sold by influencers lacking credentials to subscription services offering access to GLP-1s and other medications. It can be tricky to ...
2025 was another big year for blockbuster weight loss drugs, and their momentum does not seem to be slowing anytime soon. So as people add losing weight to their list of New Year's resolutions, they ...
Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. The launch this week of an oral pill version of Wegovy ...
Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...
The Mediterranean diet may have met its match — at least on the scale. Going Greek has long been praised as one of the healthiest ways to eat, boosting longevity and helping fend off chronic disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results